content: <HTML>
  <HEAD>
       <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font-size: 10pt">
  
  <P STYLE="margin: 0">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>UNITED STATES</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>FORM 8-K</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>CURRENT REPORT</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the Securities
  Exchange Act of 1934</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">Date of Report (Date of earliest event reported):
  June 19, 2017</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>ETHEMA HEALTH CORPORATION</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>f/k/a GREENESTONE HEALTHCARE CORPORATION</B></P>
  
  <P STYLE="margin: 0; text-align: center">(Exact name of registrant as specified in its
  charter)</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Colorado</B></FONT></TD>
      <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>000-15078</B></FONT></TD>
      <TD STYLE="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>84-1227328</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                           or other jurisdiction of</FONT></P>
          <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
          or organization)</FONT></P></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
      File Number)</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
                                           Employer</FONT></P>
          <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
          No.)</FONT></P></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5734
                                           Yonge Street, Suite 300</B></FONT></P>
          <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Toronto,
          Ontario, Canada M2M 4E7</B></FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
      of principal executive offices)</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(416)
      222-5501</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&rsquo;s
      telephone number, including area code)</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 96%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
      communications pursuant to Rule 425 under the Securities Act</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 96%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 96%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 96%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"></P><P STYLE="margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>Item 1.01</B><FONT STYLE="background-color: white">&nbsp;</FONT><B>Entry
  into a Material Definitive Agreement.</B></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">On
  June 19, 2017, Ethema Health Corporation, a Colorado corporation, f/k/a/ GreeneStone Healthcare Corporation (the &ldquo;Company&rdquo;)
  closed on a private offering (the &ldquo;Private Offering&rdquo;) to raise USD$113,500.00 in capital. Pursuant to the Private
  Offering, the Company issued one convertible promissory note (the &quot;Note&quot;), bearing a principal amount of USD$113,500.00
  in total, to Power Up Lending Limited (the &ldquo;Investor&rdquo;).</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Unless
  otherwise provided for in the Note, the Note bears a 12% interest rate and matures nine months from the date of issuance, on March
  20, 2018 (the &ldquo;Maturity Date&rdquo;). The Investor has conversion rights under the Note, from time to time and at any time
  after 180 days from the Note issuance date, to convert all or any part of the outstanding and unpaid principal amount of the Note
  into fully paid and non-assessable shares of the Company&rsquo;s common stock, subject to various other terms and conditions specified
  in the Note. The Company has the right to pay off the Note prior to 180 days from the start of the Note by paying the outstanding
  principal and interest and prepayment penalties specified in the Note. </FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  Note was offered and issued without registration under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;),
  in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act, as provided in Rule 506 of Regulation D promulgated
  thereunder. The Note, and the shares of common stock issuable upon exercise of the conversion features of the Note, have not been
  registered under the Securities Act, or any other applicable securities laws, and unless so registered may not be offered or sold
  in the United States, except pursuant to an exemption from the registration requirements of the Securities Act.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  proceeds raised in the Private Offering have been used to cover operational costs for the Company.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  foregoing description of the Note does not purport to be complete and is qualified in its entirety by reference to the form of
  the Note, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Item
  2.03</B>&nbsp;<B>Creation of a Direct Financial Obligation.</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Item
  3.02</B>&nbsp;<B>Unregistered Sales of Equity Securities.</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  applicable information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 3.02.
  In acquiring the Note, the Investor made representations to the Company that it met the accredited investor definition of Rule
  501 of the Securities Act, and the Company relied on such representations. The Note was offered and sold without registration
  under the Securities Act, in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act, as provided in Rule
  506 of Regulation D promulgated thereunder, and in reliance on similar exemptions under applicable state laws. </FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  offering of the Note was not conducted in connection with a public offering, and no public solicitation or advertisement was made
  or relied upon by the Investor in connection with the offering. This Current Report on Form 8-K shall not constitute an offer
  to sell or the solicitation of an offer to buy, nor shall such securities be offered or sold in the United States absent registration
  or an applicable exemption from the registration requirements.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Item&nbsp;9.01
  Financial Statements and Exhibits</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.
  </B>The following exhibit is furnished with this report:</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
      <TD STYLE="width: 16%; font: 12pt Times New Roman, Times, Serif; text-align: left; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
      No.</U></FONT></TD>
      <TD STYLE="width: 84%; font: 12pt Times New Roman, Times, Serif; text-align: left; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
      Description</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="grst8k062717ex10_1.htm">Form of Convertible Promissory Note, dated June 19, &nbsp;2017</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="background-color: white"><B>SIGNATURES</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Pursuant
  to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
  on its behalf by the undersigned hereunto duly authorized.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Date:
  <B>June 28, 2017</B>&#9;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">By: /s/ Shawn E. Leon</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Name: Shawn E. Leon</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"></FONT>Title: CEO</P>
  
  
  <!-- Field: Page; Sequence: 3 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
      <TD STYLE="width: 16%; font: 12pt Times New Roman, Times, Serif; text-align: left; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
      No.</U></FONT></TD>
      <TD STYLE="width: 84%; font: 12pt Times New Roman, Times, Serif; text-align: left; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
      Description</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="grst8k062717ex10_1.htm">Form of Convertible Promissory Note, dated June 19, 2017</A></FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  
  
  <P STYLE="margin: 0"></P>
  
  <!-- Field: Page; Sequence: 4; Options: Last -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"></P><P STYLE="margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0"></P>
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "grst8k062717.htm", "secsgml_size_bytes": 21989}]
metadata_filer: {"company-data": {"conformed-name": "GREENESTONE HEALTHCARE CORP", "cik": "0000792935", "assigned-sic": "8062", "irs-number": "841227328", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-15078", "film-number": "17935734"}, "business-address": {"street1": "5734 YONGE ST.", "street2": "SUITE 300", "city": "TORONTO", "state": "A6", "zip": "M2M 4E7", "phone": "416-222-5501"}, "mail-address": {"street1": "5734 YONGE ST.", "street2": "SUITE 300", "city": "TORONTO", "state": "A6", "zip": "M2M 4E7"}, "former-company": {"former-conformed-name": "NOVA NATURAL RESOURCES CORP", "date-changed": "19920703"}}
text: UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d) of the Securities
  Exchange Act of 1934
  Date of Report (Date of earliest event reported):
  June 19, 2017
  ETHEMA HEALTH CORPORATION
  f/k/a GREENESTONE HEALTHCARE CORPORATION
  (Exact name of registrant as specified in its
  charter)
  Colorado
  000-15078
  84-1227328
  (State
                                           or other jurisdiction of
  incorporation
          or organization)
  (Commission
      File Number)
  (IRS
                                           Employer
  Identification
          No.)
  5734
                                           Yonge Street, Suite 300
  Toronto,
          Ontario, Canada M2M 4E7
  (Address
      of principal executive offices)
  (416)
      222-5501
  (Registrant's
      telephone number, including area code)
  Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  [
      ]
  Written
      communications pursuant to Rule 425 under the Securities Act
  [
      ]
  Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act
  [
      ]
  Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [
      ]
  Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  Item 1.01
  Entry
  into a Material Definitive Agreement.
  On
  June 19, 2017, Ethema Health Corporation, a Colorado corporation, f/k/a/ GreeneStone Healthcare Corporation (the "Company")
  closed on a private offering (the "Private Offering") to raise USD$113,500.00 in capital. Pursuant to the Private
  Offering, the Company issued one convertible promissory note (the "Note"), bearing a principal amount of USD$113,500.00
  in total, to Power Up Lending Limited (the "Investor").
  Unless
  otherwise provided for in the Note, the Note bears a 12% interest rate and matures nine months from the date of issuance, on March
  20, 2018 (the "Maturity Date"). The Investor has conversion rights under the Note, from time to time and at any time
  after 180 days from the Note issuance date, to convert all or any part of the outstanding and unpaid principal amount of the Note
  into fully paid and non-assessable shares of the Company's common stock, subject to various other terms and conditions specified
  in the Note. The Company has the right to pay off the Note prior to 180 days from the start of the Note by paying the outstanding
  principal and interest and prepayment penalties specified in the Note.
  The
  Note was offered and issued without registration under the Securities Act of 1933, as amended (the "Securities Act"),
  in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act, as provided in Rule 506 of Regulation D promulgated
  thereunder. The Note, and the shares of common stock issuable upon exercise of the conversion features of the Note, have not been
  registered under the Securities Act, or any other applicable securities laws, and unless so registered may not be offered or sold
  in the United States, except pursuant to an exemption from the registration requirements of the Securities Act.
  The
  proceeds raised in the Private Offering have been used to cover operational costs for the Company.
  The
  foregoing description of the Note does not purport to be complete and is qualified in its entirety by reference to the form of
  the Note, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.
  Item
  2.03
  Creation of a Direct Financial Obligation.
  The
  information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03.
  Item
  3.02
  Unregistered Sales of Equity Securities.
  The
  applicable information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 3.02.
  In acquiring the Note, the Investor made representations to the Company that it met the accredited investor definition of Rule
  501 of the Securities Act, and the Company relied on such representations. The Note was offered and sold without registration
  under the Securities Act, in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act, as provided in Rule
  506 of Regulation D promulgated thereunder, and in reliance on similar exemptions under applicable state laws.
  The
  offering of the Note was not conducted in connection with a public offering, and no public solicitation or advertisement was made
  or relied upon by the Investor in connection with the offering. This Current Report on Form 8-K shall not constitute an offer
  to sell or the solicitation of an offer to buy, nor shall such securities be offered or sold in the United States absent registration
  or an applicable exemption from the registration requirements.
  Item 9.01
  Financial Statements and Exhibits
  (d)       Exhibits.
  The following exhibit is furnished with this report:
  Exhibit
      No.
  Exhibit
      Description
  10.1
  Form of Convertible Promissory Note, dated June 19,  2017
  SIGNATURES
  Pursuant
  to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
  on its behalf by the undersigned hereunto duly authorized.
  Date:
  June 28, 2017
  By: /s/ Shawn E. Leon
  Name: Shawn E. Leon
  Title: CEO
  Exhibit
      No.
  Exhibit
      Description
  10.1
  Form of Convertible Promissory Note, dated June 19, 2017